Over 50% of HIV-negative urban US gay men have anal HPV infection

Michael Carter
Published: 24 November 2004

Urban HIV-negative gay men in the USA have a high prevalence of anal infection with human papilloma virus (HPV), according to a study to be published in the December 15th edition of theJournal Infectious Diseases. Certain HPV genotypes can cause precancerous lesions and anal cancer in men. The investigators found that, unlike women, the prevalence of HPV was not age related, possibly due to the larger number of sexual partners gay men have compared to women.

No studies have examined the age-specific prevalence of HPV infection in HIV-negative gay men. In younger sexually active women have the highest prevalence of HPV infection, with the proportion of women with cervical HPV infection falling dramatically after 30. These women with persistent HPV infection have the highest risk of cervical cancer.

Investigators from the EXPLORE study, a clinical trial into the efficacy of HIV prevention interventions involving urban gay men in four large US cities, wished to establish a better understanding of the prevalence and natural history of HPV infection amongst HIV-negative men.

Between January 2001 and October 2002 a total of 1218 gay men aged 16 years or more who had had anal intercourse with another man at least once were recruited to the study. Individuals provided demographic information and details of their sexual activity using a computer-assisted self-completed questionnaire. The men also provided a swab from the anal canal which was tested for HPV and HPV genotype.

The median age of the men was 37 years, 78% were white, 72% had a college degree of higher, and 67% had an income of at least $30,000 a year. The median age of first receptive anal intercourse was 20 years. Individuals reported a median of eight sexual partners in the previous six months, and 77% reported having receptive anal sex during the previous six months.

Overall, 57% of individuals were infected with HPV. The most common HPV genotype was HPV-16, which 12% of individuals were infected with. HPV-16 is a high risk genotype for the development of precancerous lesions and anal cancer, and in total 26% of individuals were infected with a high-risk HPV genotype.

In total 45% of individuals with HPV had been infected with more than one HPV genotype.

Unlike women, the investigators found that the prevalence of HPV was similar across all age groups of gay men.

In multivariate analysis the investigators found that the only factor with a statistically significant association with HPV infection was receptive sexual intercourse in the previous six months (p < 0. 0001). The number of male sexual partners in the previous six months was of border-line significance (p = 0.06).

“The striking finding of the present study is that urban HIV-negative [gay men] have high rates of anal HPV infection across all age groups”, write the investigators, adding, “therefore, a high proportion of HIV-negative [gay men] may be at risk of developing anal cancer.”

The investigators offer possible reasons for the higher prevalence of HPV infection in older gay men than that seen in women over 30. These include the longer persistence of HPV in the anus. However, they believe that the most probable explanation is new exposure to HPV “because the main risk factor for anal HPV infection was the number of male sexual partners in the preceding six months.”

“Anal HPV infection in HIV-negative [gay men] has a unique epidemiological profile that must be carefully explored in future studies, particularly in light of new HPV therapeutic and prophylactic vaccines”, conclude the investigators.

Reference

Chin-Hong PV et al. Age-specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study. J Infect Dis 190 (on-line edition), 2004.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.